Gene-specific DNA methylation responses to Pb2+ exposure in aged male zebrafish and associations with locomotor dysfunction Authors: Chia-Chen Wu, Danielle N Meyer, Grace A Winny, Dayita Banerjee, Tracie R Baker Published: 2026 ABSTRACT AbstractLead (Pb2+) is a well-established neurotoxin that impairs motor, learning, and memory functions, particularly in children and younger adults. However, its impact on older adults remains less understood. Pb2+ toxicity involves disruption of DNA methyltransferase activity and associated epigenetic pathways, potentially altering the expression of specific genes relevant to neurological functions. As methylation patterns naturally shift during aging, Pb2+ exposure may induce additional neurological risks in aged populations. Using a zebrafish model, we investigated the combined effects of Pb2+ exposure and brain aging. Two-year-old male zebrafish were exposed to 1, 10, 100, 1000, 10 000 µg/l Pb2+ or fish water control for five days. Brain tissues were collected for DNA extraction and whole-genome bisulfite sequencing to assess global and gene-specific methylation changes. Our results found that Pb2+ exposures ≥ 100 μg/l significantly increased global methylation levels in the aged brain. Differentially methylated genes (DMGs) exhibited methylation changes within gene body regions and were mostly annotated with ion transportation and signal transduction pathways. Although only a limited number of DMGs showed corresponding changes in gene expression, several of them were associated with locomotor-related functions, including shank1 at 10 000 Pb2+ μg/l, and ptprsa, plxna2, and aopep at 100 μg/l Pb2+. These findings suggest that Pb2+ exposure during aging predominantly induces gene body-localized DNA methylation changes, and the role of such epigenetic regulation in Pb-associated neurobehavioral outcomes warrants further investigation.Keywords: methylation, zebrafish, lead (pb2+), brain, adult Introduction Despite decades of efforts to manage environmental exposures, lead (Pb2+) remains one of 10 toxicants designated by the World Health Organization (WHO) as posing major public health concerns [1]. Emerging evidence indicates that beyond its well-established neurotoxicity, Pb2+ can induce widespread epigenetic alterations, particularly changes in DNA methylation patterns [2–8]. DNA methylation primarily refers to the covalent addition of a methyl group to the 5th carbon of cytosine residues in DNA [9]. This epigenetic modification plays a crucial role in regulating gene expression, maintaining cellular identity, and mediating cellular responses to environmental stimuli [9], including contaminants such as Pb2+. Pb2+ exposure has been shown to induce abnormal DNA methylation through multiple pathways, as demonstrated in the rat hippocampus [2], mouse brain [3], and human lung and breast cancer cells [4]. In addition, human embryonic stem cells exposed to Pb2+ exhibited methylation changes in genes involved in neurogenic signaling [5]. Pb-associated methylation changes have also been reported in epidemiological studies, including alterations in Alzheimer’s disease-related genes following occupational exposure [6], CpG site-specific methylation changes in offspring following prenatal exposure [7], and hypomethylation of interspersed DNA repeats such as Long Interspersed Nucelotide Element 1 (LINE-1) in children [10]. Furthermore, the Normative Aging Study cohort identified specific blood DNA methylation CpG sites corresponding with cumulative Pb2+ concentrations within bone, demonstrating a longitudinal relationship with Pb accumulation throughout the aging trajectory [8]. The exposure window of Pb2+ plays a critical role in shaping its health effects and associated epigenetic consequences. During early life, when neuronal cells are highly proliferative, Pb2+ exposure can reduce the expression of DNA methyltransferases and other regulators of methylation in the hippocampus [2]. This impairment of the methylation machinery following developmental Pb2+ exposure induces long-lasting DNA methylation modifications that persist into old age, leading to altered expression of neuronal maintenance genes and rendering the aging brain more susceptible to age-related degeneration [11]. Other than the effects of developmental exposure, aging itself is associated with dynamic changes in the brain’s DNA methylation landscape. In the adult brain, neurons continue to express significant levels of DNA methyltransferases, suggesting an ongoing role for DNA methylation in brain function beyond development [9]. Age-related changes in DNA methylation exhibit dynamic patterns, including neuronal activity-dependent demethylation [12]. In aged brain tissues, however, hypermethylation of synaptic genes associated with cognitive decline has been observed [13]. Nevertheless, how Pb2+ exposure impacts the epigenetic regulation of aged brain tissues remains poorly understood. Given the growing proportion of older adults globally [14], investigating how environmental Pb2+ exposures interact with the aging epigenome is critical for advancing mechanistic insight and informing public health strategies. In this study, we hypothesized that Pb2+ exposure induces transcriptomic changes through methylation regulation. Our previous work demonstrated that acute Pb2+ exposure altered locomotor, anxiety-level behaviors, and associated transcriptomic profiles in zebrafish at 2 years of age [15]. In addition, several studies have suggested that Pb2+-induced behavioral impairments are more pronounced in males [16, 17]. At advanced life stages, zebrafish exhibit decreased global genome methylation compared to younger individuals [18], reflecting aging-associated epigenetic alterations. Zebrafish and humans also share common functional characteristics related to cognitive decline [19] and genome instability [18], supporting the use of zebrafish as a representative model for studying aging-related processes in human populations. Building on these findings, we conducted whole-genome bisulfite sequencing (WGBS) on the brains of 2-year-old zebrafish following 5 days of Pb2+ exposure, during which behavioral and transcriptomic changes were observed. Thus, this study sought to characterize Pb2+-induced DNA methylation alterations in the aged male zebrafish brain and examine their associations with previously observed behavioral and transcriptomic responses. Results A total of 19 489, 7907, 22 923, 19 555, and 22 376 CpG sites were significantly differentially methylated in the brain tissue of the 2-year-old zebrafish following 1, 10, 100, 1000, and 10 000 μg/l Pb2+ exposure (Fig. 1). Among them, 100 and 10 000 μg/l resulted in the highest number of differentially methylated CpG sites (DMCs), whereas 10 μg/l had the fewest. More than 85% of the DMCs were hypermethylated across all exposure levels. Hypomethylation accounted for <5% of DMCs. The average genome-wide methylation levels from 0, 1, 10, 100, 1000, and 10 000 μg/l were 78 ± 3%, 83 ± 3% (P = .09 compared to control), 82 ± 3% (P = .21 compared to control), 85 ± 3% (P = .011 compared to control), 84 ± 1% (P = .018 compared to control), and 84 ± 1% (P = .018 compared to control). These results indicate that exposure to Pb2+ levels ≥ 100 μg/l led to significantly increased global methylation compared to the control in aged zebrafish. Number of differentially methylated CpG sites (DMCs) in 2-year-old male fish following Pb2+ exposure across 1, 10, 100, 1000, and 10 000 μg/l. DMCs with an absolute methylation difference >0.3 were classified as strongly hypermethylated or strongly hypomethylated. DMCs with an absolute difference ≤0.3 were classified as hypermethylated or hypomethylated. Bars represent the total number of DMCs by methylation category (n = 3 replicates per exposure group). Considering the genomic context of DMCs, we annotated their relative positions within promoter regions and gene bodies. Overall, 85% of DMCs were located in gene bodies. Among promoter-associated regions, 12% were located within −1500 to + 500 bp relative to the transcriptional start site (TSS), including 3% within −300 to +150 bp, and 1% within −50 to +50 bp. Across Pb2+ exposure levels of 1, 10, 100, 1000, and 10 000 μg/l, the number of unique differentially methylated genes (DMGs), defined as genes containing at least one DMC, were 1813, 1135, 1853, 1719, and 1992, respectively (Fig. 2). Consistent with global methylation patterns, the 10 and 1 μg/l Pb2+ exposures had the lowest methylation difference across all genomic regions compared to the other three exposures. Distribution of average methylation differences per gene across genomic regions (n = 3 replicates per exposure group). Genomic locations are defined as −1500 to +500 bp relative to the transcription start site (TSS), −300 to + 150 bp, −50 to +50 bp, and the gene body. Each dot is one DMG, with its value representing the average methylation difference of all differentially methylated CpG sites assigned to that gene within the specified genomic region. To identify biological pathways associated with the methylome, DMGs were analyzed using Database for Annotation, Visualization, and Integrated Discovery (DAVID, version 2021) (Fig. 3). Cell adhesion (KW-0130) and ion transport (KW-0406) were the most consistently implicated pathways across all five Pb2+ exposure levels. Transport (KW-0813) was another major pathway, observed at all exposure levels except 10μg/l. At the highest Pb level, the methylome was linked to the greatest number of biological pathways, with transport (KW-0813), ion transport (KW-0406), cell adhesion (KW-0130), and neurogenesis (KW-0524) as the four most prominent pathways. Additionally, lipid transport (KW-0445) and angiogenesis (KW-0037) were uniquely present at this exposure level. Biological pathways associated with DMGs in 2-year-old zebrafish following 1, 10, 100, 1000, and 10 000 μg/l Pb2+ exposure (n = 3 replicates per exposure group). The legend for the pie charts is located at the top left of the figure, followed by pie charts representing biological pathways at different Pb2+ exposure levels: (A) 1 μg/l, (B) 10 μg/l, (C) 100 μg/l, (D) 1000 μg/l, and (E) 10 000 μg/l. To investigate the relationship between methylation changes and Pb2+ exposure levels, Spearman correlation analyses were performed between the average DNA methylation levels of individual DMG and the corresponding log-transformed Pb2+ concentrations. Genes with an absolute Spearman correlation coefficient of 1, a P-value < .05, and an absolute average methylation level ≥0.3 at at least one Pb concentration were included in Figure S1 and Table S1. Among these, genes associated with the biological pathways described above are shown in Fig. 4. DMGs with average methylation levels correlated with Pb2+ exposure (n = 3 replicates per exposure group). Genes with an absolute Spearman correlation coefficient of 1, a P-value < .05, and an absolute average methylation level ≥ 0.3 at at least one Pb concentration are shown. Color intensity indicates the average methylation level. The left column shows gene symbols, and the associated biological pathways are listed in the right column. Differential methylation for all genes was located within the gene body regions. Specifically, genes exhibiting a consistent increase in methylation with increasing Pb2+ concentrations included pdzd8 (PDZ domain containing 8), stat3 (signal transducer and activator of transcription 3), and tns1a (tensin 1a). Some DMGs showed an overall increasing trend across most Pb2+ concentrations, excluding 100 μg/l in mlycd (malonyl-CoA decarboxylase) and ccdc125 (coiled-coil domain containing 125), and 10 μg/l in znf1021 (zinc finger protein 1021), znf569l (zinc finger protein 569, like), ctsk (cathepsin K), csnk1g2b (gamma 2b casein kinase 1), and adam17b (ADAM metallopeptidase domain 17b). In contrast, several genes showed an inverse relationship between Pb2+ concentrations and methylation level, including atp2b2 (ATPase plasma membrane Ca2+ transporting 2) and palld (palladin, cytoskeletal-associated protein). Other DMGs also exhibited non-monotonic patterns, with igfbp2b (insulin-like growth factor binding protein 2b), ipo13 (importin 13b), cul3a (cullin 3a), and fzd3b (frizzled class receptor 3b) showing deviations at 10 μg/l, and tafa5l (TAFA chemokine-like family member 5, like) at 100 μg/l. All abovementioned genes exhibited differential methylation within gene body regions (Table S1). We further examined the correlation between methylation levels of individual DMCs and Pb2+ exposure concentrations using Spearman correlation analyses. The complete list of correlated DMCs is provided in Table S2. Figure 5 shows eighteen genes containing more than five DMCs that were significantly correlated with more than three Pb2+ concentrations (Spearman correlation, P-value < .05). These DMCs were all located within gene body regions. Multiple strongly hypermethylated DMCs (methylation difference relative to control >0.3) were located in regions of the genes, including cerkl (CERK like autophagy regulator), mindy3 (MINDY lysine 48 deubiquitinase 3), klc1a (kinesin light chain 1a), atrnl1a (attractin-like 1a), eeig1a (estrogen-induced osteoclastogenesis regulator 1a), tbc1d1 (tyrosyl-DNA phosphodiesterase 1), rptor (regulatory associated protein of MTOR, complex 1), myh9b (myosin heavy chain 9b), fat1a (FAT atypical cadherin 1a), and several zinc finger (znf) genes, including znf1115, znf1030, znf1102, znf1085, and znf1096. In contrast, genes such as aars1 (alanyl-tRNA synthetase 1), oat (ornithine aminotransferase), abtb2b (ankyrin repeat and BTB (POZ) domain containing 2b), tdp1 (tyrosyl-DNA phosphodiesterase 1), and znf1042 contained DMCs with methylation differences between 0.09 and 0.29. Most DMCs showed the lowest degree of change at 10 μg/l exposure. Differentially methylated CpG sites (DMCs) significantly correlated with Pb2+ exposure levels and their associated genes (Spearman correlation, P < .05) (n = 3 replicates per exposure group). CpG sites are denoted by genomic coordinates, where the first number indicates the chromosome and the second number indicates the genomic start position. All DMCs were located within the gene body region. Heatmap colors indicate methylation differences relative to controls across Pb2+ exposure concentrations. The identified DMGs showed limited overlap with previously reported transcriptomic responses [15] (Table S3). Table 1 summarizes 20 genes that exhibited both differential methylation and differential expression at more than one Pb2+ concentration across 100 to 10 000 μg/l, ranked from the highest to the lowest magnitude of methylation changes. Among them, seven genes showed a pattern of hypermethylation accompanied by downregulation, including rab11bb (RAB11B, member RAS oncogene family), vps39 (VPS39 subunit of HOPS complex), ppfia4 (PTPRF interacting protein alpha 4), pip5k1c (Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma b), lrp8 (LDL receptor-related protein 8), aopep (Aminopeptidase O), and wbp11 (WW domain binding protein 11). One gene, ctsa (Cathepsin A), exhibited hypomethylation with upregulation. The remaining genes displayed both hypermethylation and upregulation. Notably, fndc3a (Fibronectin type III domain containing 3A), shank1 (SH3 and multiple ankyrin repeat domains 1), and dock3 (Dedicator of cytokinesis 3) showed the largest methylation changes (up to 0.38), accompanied by strong upregulation (log₂FC ≥ 1.5). Most of these genes did not follow a sequential dose–response trend between methylation levels and Pb2+ concentrations. Exceptions include stat3, which showed a consistent increase in average methylation, and msantd4, which showed slight CpG site-specific correlation across non-consecutive Pb2+ levels. Among these genes, only ptprsa (PTPRF interacting protein alpha 4), msantd4 (Myb/SANT-like DNA-binding domain containing 4 with coiled-coils), and wbp11 contained DMCs located in promoter-associated regions, whereas the remaining overlapped genes exhibited methylation changes within gene body regions. Table 1Genes with overlapping differential methylation and expression at the same Pb2+ concentration, corresponding to peak expression level.Gene nameFull gene nameGenomic locationDifferential methylation changes (Pb2+)Log2 fold changes (Pb2+) fndc3a Fibronectin type III domain containing 3AGene body0.38 (10 000)1.5 (10 000) shank1 SH3 and multiple ankyrin repeat domains 1Gene body0.34 (10 000)1.5 (10 000) dock3 Dedicator of cytokinesis 3Gene body0.32 (10 000)1.3 (10 000) rab11bb RAB11B, member RAS oncogene familyGene body0.27 (10 000)–1.0 (10 000) plxna2 Plexin A2Gene body0.26 (100)1.06 (100) frs3 Fibroblast growth factor receptor substrate 3Gene body0.25 (10 000)1.6 (10 000) ptprea protein tyrosine phosphatase receptor type EaGene body0.24 (10 000)1.2 (10 000) myh9b Myosin, heavy chain 9b, non-muscleGene body0.23 (10 000)1.3 (10 000) vps39 VPS39 subunit of HOPS complexGene body0.23 (10 000)–1.1 (10 000) stat3 Signal transducer and activator of transcription 3Gene body0.21 (1000)1.58 (1000) ppfia4 PTPRF interacting protein alpha 4Gene body0.21 (1000)–1.1 (1000) ptprsa Protein tyrosine phosphatase receptor type Sa−1500 to +500 bp to TSS; gene body0.19 (100)1.5 (100) pip5k1c Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma bGene body0.19 (1000)–1.4 (1000) msantd4 Myb/SANT-like DNA-binding domain containing 4 with coiled-coils−1500 to +500 bp to TSS0.18 (10 000)2.7 (10 000) adam11 ADAM metallopeptidase domain 11Gene body0.18 (1000)2.5 (1000) rab21 RAB21, member RAS oncogene familyGene body0.18 (10 000)2.4 (10 000) lrp8 LDL receptor related protein 8Gene body0.17 (100)–0.8 (100) aopep Aminopeptidase O (putative)Gene body0.16 (100)–1.3 (100) wbp11 WW domain binding protein 11−1500 to +500 bp to TSS0.15 (100)–1.7 (100) ctsa Cathepsin AGene body–0.12 (1000)1.5 (1000) Genes with overlapping differential methylation and expression at the same Pb2+ concentration, corresponding to peak expression level. Discussion Our findings reveal that Pb2+ exposure at concentrations ≥ 100 μg/l induces widespread gene body methylation in the brains of aged zebrafish. Gene body methylation is an epigenetic feature that has been proposed to play roles in silencing repetitive DNA elements, regulating transcriptional elongation, modulating alternative splicing, and influencing other regulatory elements such as enhancers or insulators [20]. In contrast to promoter methylation, where strong methylation is typically associated with transcriptional repression, gene body methylation has been reported to correlate with active transcription in moderately to highly expressed genes [21]. Additionally, it has been found that methylation at specific CpG sites within gene bodies is strongly associated with aging in zebrafish tissues, including the caudal fin [22]. These findings highlight the importance of Pb-associated methylation changes at specific genomic sites, which may have functional consequences relevant to aging-related neurological disorders. We observed limited overlap between genes showing both differential expression and differential methylation. Similarly, previous analyses of adult zebrafish brain methylomes in comparison with gene differential expression profiles show limited overlap [23]. Notably, in the adult zebrafish brain methylome dataset, the DMCs within the genes that were both differentially expressed and methylated were also predominantly located in gene bodies or intergenic regions, rather than in promoters [23]. This pattern aligns with previous findings that the functional role of gene body methylation may depend on cell differentiation status [12, 24]. Given that our data were derived from whole-brain homogenates, potential cell-type or region-specific methylation patterns may have been masked. In addition, the nominal exposure concentrations may not reflect the effective uptake of Pb2+ in tissues, making the Pb-induced responses not apparent in dose–response pattern. Nevertheless, the genes that exhibited apparent methylation trends with Pb2+ exposure in our study may represent robust and integrative signals under aged conditions. We therefore focused on these genes in the following discussion. Since our previous study reported locomotor and anxiety-like behavioral changes in aged zebrafish following non-monotonic Pb2+ exposure [15], we examined DMGs that may be associated with these behavioral phenotypes. These genes included tdp1, klc1, tns1a, shank1, ptprsa, plxna2, aopep, and adam11. Interestingly, the last five DMGs were also differentially expressed, with tns1a and shank1 showing the highest differential expression at 10 000 μg/l Pb2+, ptprsa, plxna2, and aopep at 100 μg/l Pb2+, and adam11 at 1000 μg/l Pb2+. Tdp1, which has been implicated in adult locomotor activity, has been shown to cause mild locomotor impairment when deleted [25]. Consistent with our earlier findings implicating cytoskeletal organization [15], klc1 [26], tns1a [27], and shank1 [28] are involved in the tubulin-associated cytoskeletal network specifically at 10 000 μg/l Pb2+. Klc1 encodes a subunit of kinesin-1 motor complex responsible for anterograde axonal transport, a process critical for proper neurotransmission. Shank1, a gene primarily expressed in the synapse, was hypermethylated only at 10 000 μg/l and upregulated at both 100 and 10 000 μg/l Pb2+. Hypermethylation of shank1, shank2, and shank3 has been observed in brain and blood samples of epilepsy patients [29]. Among the remaining DMGs, ptprs deletion leads to early-life neurological deficits, motor dysfunction, impaired synaptic input, and high postnatal mortality [30], as well as memory impairment during juvenile stage [31]. Plxna2 encodes Plexin A2, a receptor involved in plexin signaling pathways that regulate neuronal development, including proliferation, migration, and positioning [32]. Both animal and human clinical observations have linked plxna2 to motor function and cognitive ability [33, 34]. In addition, single-nucleotide polymorphisms and variant studies have associated plxna2 with cognitive-related disorders, including autism spectrum disorder [35], schizophrenia [36], and cognitive aging [37]. Aopep encodes a zinc-dependent aminopeptidase involved in synaptogenesis and neural maintenance [38]. Variants in aopep have been identified in individuals with autosomal recessive dystonia [39], suggesting its relevance to motor dysfunction. Lastly, adam11 encodes a membrane-anchored protein implicated in neurogenesis, learning, and motor coordination [40]. Among the genes showing clear methylation trends across Pb2+ concentrations, several were involved in pathways critical to neuronal signal transduction and ion transportation, most notably calcium homeostasis and Wnt signaling. Several DMGs involved in calcium signaling showed dose–response patterns with Pb2+ exposure, including fat1a, atp2b2, and pdzd8. Fat1a showed non-monotonic methylation changes at CpG sites across increasing Pb2+ concentrations, whereas average pdzd8 methylation was directly correlated and atp2b2 methylation was inversely correlated with Pb2+ exposure levels. Among them, atp2b2 encodes a plasma membrane ATPase that regulates intracellular Ca2+ homeostasis in the brain [41]. Altered methylation and expression of atp2b2 have also been identified in the prefrontal cortex of patients with schizophrenia [42]. Pdzd8 has previously exhibited hypomethylation in blood and brain samples from Alzheimer’s disease patients of both sexes [43]. In contrast, our study found increasing hypermethylation of pdzd8 with higher Pb2+ concentrations in the aged male zebrafish brain. While most studies on Pb-induced disruption of calcium homeostasis focus on physiological ion competition, other findings support the possibility of epigenetic regulation as an additional mechanism. These findings suggest that Pb2+ exposure may disrupt calcium homeostasis in the aged brain through epigenetic modifications of key calcium signaling genes. Beyond calcium signaling, differential methylation of fzd3b, csnk1g2b, and adam17b all point to Wnt signaling as another pathway potentially disrupted by Pb2+ exposure. Among them, fzd3b exhibited hypomethylation, whereas csnk1g2b and adam17b showed hypermethylation with increasing Pb2+ concentrations. Fzd3d encodes a Frizzled receptor that mediates both canonical and non-canonical Wnt signaling. In the canonical pathway, CSNK1G2 activates the Wnt signaling by phosphorylating LRP co-receptors, such as LRP5 and LRP6. In our study, we also identified a member of the LRP family, lrp8, as a DMG. Lrp8 was hypermethylated and downregulated at Pb2+ concentrations ≥ 100 μg/l. Although LRP8 is less well-characterized than LRP5/6 in Wnt signaling, its structural similarity suggests potential involvement. Additionally, adam17b gene expression has been activated by canonical Wnt signaling through chromatin remodeling and histone demethylation in colorectal cancer cells [44]. On the other hand, the locomotor-related gene shank1 is involved in synapse maturation by modulating noncanonical Wnt signaling during neuronal development [45]. In line with our finding, a previous study of brain samples from Parkinson’s disease patients reported that genes involved in Wnt signaling showed abnormal DNA methylation and expression, although the study did not specify whether the canonical or non-canonical Wnt pathways were predominantly affected [46]. While much of the existing research has focused on how developmental Pb2+ exposure inhibits Wnt signaling and leads to premature neural differentiation [47] and altered synaptogenesis [48], our study is the first to identify Wnt-related genes in aged organisms whose methylation and/or expression may be altered in response to Pb2+ exposure. In addition to Wnt signaling, several DMGs showing consistent methylation trends with increasing Pb2+ exposure—adam17b, klc1, and ptprs—have been implicated in Alzheimer’s disease through amyloid- or tau-regulated pathways. Adam17b encodes a disintegrin and metalloprotease that cleaves the amyloid precursor protein (APP) at the α-secretase site. By promoting non-amyloidogenic APP processing and reducing amyloid-β accumulation, ADAM17 has been proposed as a therapeutic target for Alzheimer’s disease [49]. In our analysis, adam17b displayed a consistent increase in methylation with Pb2+ concentrations ≥ 100 μg/l, although it was not differentially expressed at the transcript level [15]. While studies have demonstrated that adam17b expression can be suppressed by miRNA in glioma cells [50], the specific role of DNA methylation in regulating adam17b expression in neural-related tissues or cells remains unclear. Another DMG associated with amyloid-β accumulation is klc1. Reduced expression of KLC1 protein has been shown to impair APP trafficking, thereby contributing to amyloid plaque formation in Alzheimer’s disease [51] [52]. In contrast to adam17 and klc1a, which influence amyloidogenic processes, ptprs has been more directly linked to tau pathology. Ptprs encodes a member of the protein tyrosine phosphates (PTP) family, whose phosphatase activity can prevent tau hyperphosphorylation [53], suggesting a neuroprotective role in early-stage tau pathology in Alzheimer’s disease. In our study, ptprs exhibited both hypermethylation and upregulation, though the pattern was not clearly Pb2+ dose-dependent. The altered methylation patterns observed in, klc1a, and ptprs suggest that key Alzheimer’s disease–related genes may serve as epigenetically modifiable biomarkers of Pb²⁺ exposure, with potential implications for movement and broader neurological dysfunctions. Among the DMGs showing overlapping differential expression, msantd4 and wbp11 were further examined due to their specific CpG hypermethylation within the promoter-proximal region, −1500 bp to + 50 bp relative to the TSS. Msantd4 encodes a DNA-binding protein expressed during zebrafish embryonic development and in adult tissues, predominantly in the male brain, as well as in the human brain during fetal development [54]. Knockdown of msantd4 has been shown to result in nervous system malfunction and impaired brain ventricle formation [54]. Wbp11 encodes a nuclear protein involved in RNA splicing, mRNA processing, and rRNA processing [55]. Although both genes are relatively understudied, their promoter-proximal methylation changes and differential expression in response to Pb2+ exposure suggest they may be involved in epigenetic regulation in the aged brain. This study employed a controlled experimental design to examine Pb2+ exposure and its epigenetic impacts in an aged zebrafish model. Pb2+ exposure in aged zebrafish predominantly induces gene body-localized DNA methylation with minimal overlap with differentially expressed genes. Several of these DMGs are associated with motor functions, including shank1 in response to high Pb2+ insult, and ptprsa, plxna2, and aopep at 100 μg/l Pb2+, consistent with previously observed Pb-induced behavioral alterations. Given that Pb2+ exposure at concentrations ≥ 100 μg/l increased global methylation in the aged brain, its potential contribution to locomotor dysfunction and neurodegeneration-related diseases through gene body methylation-mediated regulatory mechanisms warrants further investigation. Future studies incorporating long-term Pb2+ exposure and direct quantification of Pb uptake will be critical for clarifying gene-specific dose–response relationships and their functional consequences. Materials and methods Animals Zebrafish (AB wildtype fish line) were housed in a recirculating aquatic housing system. Routine husbandry and care were provided by trained laboratory personnel. All animal procedures were approved by the Animal Care and Use Committee at Wayne State University (protocol number 19-02-0938) and were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Zebrafish husbandry followed established husbandry protocol and guidelines described by Westerfield [56]. Acute Pb2+ exposure Two-year-old zebrafish were exposed to waterborne lead acetate (Sigma-Aldrich, St. Louis, MO, USA) at nominal concentrations of 1, 10, 100, 1000, and 10 000 μg/l, or to a fish water control for five consecutive days. The exposure levels spanned environmentally relevant concentrations (1–100 µg/l) [57, 58] through higher levels up to 10 000 µg/l to assess acute toxicity responses to high-insult conditions. Four aged zebrafish were assigned to each exposure group. Each exposure group was conducted in 1.5 l beakers containing 800 ml exposure solution. To maintain water quality, 80% of the water was renewed daily with freshly prepared exposure solutions. As previous studies have reported sex-dependent behavioral impairment and transcriptomic alterations following Pb2+ exposure [16, 17], only aged male zebrafish were used in this study. Genomic DNA isolation and library preparation Three adult male zebrafish from each exposure group were selected for WGBS analysis. Fish were euthanized using 16.7 mg/ml tricaine methanesulfonate solution. Brains were dissected and preserved in RNALaterTM (Thermo Fisher, Waltham, MA, USA) at −80°C until nucleic acid extraction. Prior to extraction, RNALaterTM was removed from the tissue. Genomic DNA extraction was extracted using the Quick-DNA/RNATM Miniprep plus Kit (Zymo, Irvine, CA, USA) according to the manufacturer’s protocol. Briefly, each individual brain sample was pretreated with 95 μl DNase/RNase-free water, 95 μl PK digestion buffer, and 10 μl proteinase K, followed by incubation at 55°C for 30 min and an additional incubation at 94°C for 20 min. After incubation, samples were centrifuged at 10 000 × g for 30 s. The resulting supernatant was mixed with DNA/RNA lysis buffer at a 1:1 ratio and loaded onto spin columns for DNA purification. DNA concentrations were quantified using the Qubit dsDNA High Sensitivity Assay Kit (Thermo Fisher, Waltham, MA, USA). DNA methylation library preparation was performed by the University of Florida Interdisciplinary Center for Biotechnology Research core using Illumina NEB Enzymatic-based Methylation library preparation kits (Ipswich, MA, USA) according to the manufacturer’s instructions. WGBS sequencing and bioinformatics Paired-end sequencing of the WGBS libraries was performed on a NovaSeq 6000 platform (S4 flow cell, 2 × 150 bp, one lane) (Illumina, CA, USA) at the University of Florida Interdisciplinary Center for Biotechnology Research core. Triplicates for each exposure group were sequenced, and each biological sample contained ~120 million paired-end reads. Short reads were trimmed using Trimmomatic (v 0.36) [59], and quality control was assessed on both original and trimmed reads using FastQC (v 0.11.4) [60] and MultiQC [61]. Trimmed reads were aligned to the zebrafish genome (danRer, GRCz11 assembly) using BSMAP [62]. Methylation calling was performed with cscall v1.0 [63] using the danRer.GRCz11-CG index. A CpG site was included in downstream analysis if it reached a minimum coverage of 20 reads in at least two samples. Differential methylation analysis was conducted using the “mcomp” program and part of moabs package [64]. Differentially methylated CpG sites (DMCs) were defined as CpG with a P-value < .01 when comparing methylation rates between control and exposed groups. DMCs showing a methylation difference above 0.3 were classified as strongly hypermethylated or strongly hypomethylated, with those with difference ≤0.3 were classified as hypermethylated or hypomethylated. The average genome-wide methylation was calculated as the mean of all CpG methylation rates across the genome and compared between groups using a two-sample t-test. DMGs were called when at least one DMC was located within the gene body or within promoter regions defined as −1500 to +500 bp, −300 to +150 bp, or −50 to +50 bp relative to the TSS [65]. The average difference in methylation level across all DMCs within each gene was then calculated between control and exposed groups. Genes were classified as DMGs if the P-value < .01 when comparing between control and exposed groups using a two-sample t-test. DMGs were categorized as strongly hypermethylated or strongly hypomethylated if the absolute average difference exceeded 0.3, and as hypermethylated or hypomethylated if ≤0.3. Pathway analysis DMGs were subjected to gene enrichment and functional annotation clustering analysis using the Database for Annotation, Visualization, and Integrated Discovery (DAVID, version 2021) [66, 67]. UniProtKB Keywords (UP_KW) were considered significantly enriched when the Benjamini-adjusted false discovery rate was <0.05. Supplementary Material Acknowledgment We would like to acknowledge the University of Florida Interdisciplinary Center for Biotechnology Research core for providing WGBS service and bioinformatics support. We would also like to thank past and present members of the Warrior Aquatic, Translational, and Environmental Research (WATER) lab for their assistance with fish husbandry and laboratory maintenance as well as their general advice on and support of this project, including fish rearing, exposure, and data collection of this study. Contributor Information Chia-Chen Wu, Institute of Environmental Engineering, National Yang Ming Chiao Tung University, Hsinchu City 300093, Taiwan. Danielle N Meyer, Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, United States. Grace A Winny, Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, United States. Dayita Banerjee, Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, United States. Tracie R Baker, Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, United States; University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, United States. Author contributions Chia-Chen Wu (Conceptualization [supporting], Data curation [lead], Formal Analysis [lead], Funding acquisition [supporting], Investigation [lead], Methodology [lead], Supervision [supporting], Validation [lead], Visualization [lead], Writing – original draft [lead]), Danielle N Meyer (Data curation [supporting], Investigation [supporting], Supervision [supporting], Validation [supporting], Writing – review & editing [lead]), Grace A Winny (Data curation [supporting], Investigation [supporting], Writing – review & editing [supporting]), Dayita Banerjee (Data curation [supporting], Investigation [supporting], Writing – review & editing [supporting]), Tracie Renee Baker (Conceptualization [lead], Funding acquisition [lead], Methodology [equal], Project administration [lead], Supervision [lead], Writing – review & editing [equal]) Conflicts of interest None declared. Funding This work was supported by the National Institute of Environmental Health Sciences (R01 ES034878 to T.R.B. and C.C.W.). Data availability 622 Data is included in the Supplemental files and will be made available upon reasonable request to the corresponding author, Dr. Tracie Baker, tracie.baker@ufl.edu. References Associated Data Supplementary Materials Data Availability Statement 622 Data is included in the Supplemental files and will be made available upon reasonable request to the corresponding author, Dr. Tracie Baker, tracie.baker@ufl.edu.